Renaud Sabatier

19PUBLICATIONS
76CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersCancer geneticsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 11, 2025
PARP inhibitors as maintenance therapy in ovarian cancer after platinum-sensitive recurrence: real-world experience from the Unicancer network.

Nicolas Rippstein, Christophe Zemmour, Manuel Rodrigues

|Jan 31, 2025
Tertiary Lymphoid Structures Are Associated with Enhanced Macrophage Activation and Immune Checkpoint Expression and Predict Outcome in Cervical Cancer.

Laurent Gorvel, Marylou Panouillot, Marie-Sarah Rouvière

|Dec 14, 2024
Safety and quality of life with maintenance olaparib plus bevacizumab in older patients with ovarian cancer: subgroup analysis of PAOLA‑1/ENGOT-ov25.

Coline Montégut, Claire Falandry, Saverio Cinieri

|Nov 27, 2024
Deciphering Folate Receptor alphaGene Expression and mRNA Signatures in Ovarian Cancer: Implications for Precision Therapies.

Maria Kfoury, Pascal Finetti, Emilie Mamessier

|Sep 18, 2024
Atezolizumab Combined With Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer With a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial.

Antonio González-Martín, María Jesús Rubio, Florian Heitz

|Jun 26, 2024
Endometrioid ovarian carcinoma landscape: pathological and molecular characterization.

Alexandre de Nonneville, Elsa Kalbacher, Francesco Cannone

Pageof 4

Frequent Collaborators

7 joint publications

Anthony Gonçalves

4 joint publications

François Bertucci

4 joint publications

Isabelle Ray-Coquard

3 joint publications

Alexandre de Nonneville